Indeed, an examination of gene expression profiles from multiple datasets of PCa patients revealed a significant reduction in FOXA1 transcript levels as the cancer progresses from its primary state to CRPC (Supplementary Figure S16D–G). This evidence concerns the gene FOXA1 and cancer.